Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TB Multi-drug Resistant”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241
Not applicableStudy completedNCT03470233
What this trial is testing

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Korea Otsuka Pharmaceutical Co., Ltd. 149
Not applicableStudy completedNCT03000517
What this trial is testing

PK of Levofloxacin in MDR-TB Patients

Who this might be right for
Multi-drug Resistant Tuberculosis
University Medical Center Groningen 20
Not applicableStudy completedNCT07167823
What this trial is testing

The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront

Who this might be right for
Pleural EmpyemaTuberculosis (TB)Bacterial Sepsis
University of Health Sciences Lahore 350
Not applicableStudy completedNCT07058233
What this trial is testing

Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial

Who this might be right for
Tuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb
RSUP Persahabatan 70
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Not applicableLooking for participantsNCT05117788
What this trial is testing

Bioneer Q-RFIA Clinical Evaluation

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 2,350
Large-scale testing (Phase 3)Looking for participantsNCT06905522
What this trial is testing

A PAN-USR TB Multi-Center Trial

Who this might be right for
Pulmonary Tuberculosis
Shenzhen Third People's Hospital 610
Not applicableApproved For MarketingNCT01464762
What this trial is testing

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA
Testing effectiveness (Phase 2)Study completedNCT01859923
What this trial is testing

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

Who this might be right for
Multidrug Resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Not applicableUnknownNCT00676754
What this trial is testing

Epidemiology of MDR-TB in Peru

Who this might be right for
TB Multi-drug Resistant
Harvard University Faculty of Medicine 18,544
Not applicableStudy completedNCT02729532
What this trial is testing

Effect of Xpert MTB/RIF on Patient Outcomes

Who this might be right for
Tuberculosis
University of North Carolina, Chapel Hill 776
Not applicableStudy completedNCT03822156
What this trial is testing

Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort

Who this might be right for
TuberculosisTuberculosis, PulmonaryCavity+5 more
University of Ulsan 500
Early research (Phase 1)UnknownNCT03575299
What this trial is testing

Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells

Who this might be right for
Multi-drug Resistant Tuberculosis
Zhinan Yin, Ph.D. 45
Post-approval studies (Phase 4)UnknownNCT06476210
What this trial is testing

The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

Who this might be right for
Pulmonary Tuberculosis
Beijing Chest Hospital 45
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Not applicableUnknownNCT03507816
What this trial is testing

A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace

Who this might be right for
Tuberculosis
University Hospital, Strasbourg, France 22
Large-scale testing (Phase 3)Study completedNCT04062201
What this trial is testing

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Who this might be right for
TuberculosisPre-XDR-TBExtensively Drug-Resistant Tuberculosis+2 more
Wits Health Consortium (Pty) Ltd 402
Large-scale testing (Phase 3)Study completedNCT02454205
What this trial is testing

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

Who this might be right for
TuberculosisMultidrug Resistant TuberculosisExtensively-drug Resistant Tuberculosis
University of Cape Town 154
Large-scale testing (Phase 3)Study completedNCT04207112
What this trial is testing

Economic Evaluation of New MDR TB Regimens

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculoses
Medecins Sans Frontieres, Netherlands 73
Next Page